Anti-PD-1 Antibody SHR-1210 Combined with Apatinib as Adjuvant Treatment in Patients with Hepatocellular Carcinoma at High Risk of Recurrence after Radical Resection: Preliminary Results from a Multicenter, Randomized, Controlled Phase 2 Trial
Apatinib;SHR-1210
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Anti-PD-1 Antibody SHR-1210 Combined with Apatinib as Adjuvant Treatment in Patients with Hepatocellular Carcinoma at High Risk of Recurrence after Radical Resection: Preliminary Results from a Multicenter, Randomized, Controlled Phase 2 Trial ### Output: Apatinib;SHR-1210